![Body weight independent effects of CT-868, a signalling biased dual GLP-1/GIP receptor modulator, on glucose homeostasis in overweight and obese adults with type 2 diabetes thumbnail](https://prosciento.com/wp-content/uploads/2023/10/Weight-independent-effects-of-CT-868-a-signaling-biased-dual-GLP-1-GIP-receptor-modulator-on-glucose-homeostasis-in-overweight-and-obese-adults-with-type-2-diabetes-thumb-1.jpg)
Body weight independent effects of CT-868, a signalling biased dual GLP-1/GIP receptor modulator, on glucose homeostasis in overweight and obese adults with type 2 diabetes
Publication Authors:
M. Chakravarthy, M. Hernandez, M. Elliott, A. Macias, S. Hansen1, M. Hompesch
Presented at EASD 2023, October 2-6, 2023
![Body weight independent effects of CT-868, a signalling biased dual GLP-1/GIP receptor modulator, on glucose homeostasis in overweight and obese adults with type 2 diabetes thumbnail](https://prosciento.com/wp-content/uploads/2023/10/Weight-independent-effects-of-CT-868-a-signaling-biased-dual-GLP-1-GIP-receptor-modulator-on-glucose-homeostasis-in-overweight-and-obese-adults-with-type-2-diabetes-thumb-1.jpg)